medroxyprogesterone
information and resources from the National Cancer Institute
medroxyprogesterone
A synthetic derivative of progesterone administered as an acetate salt (medroxyprogesterone acetate) with antiestrogenic activity. As a do all progestins, medroxyprogesterone binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of estrogen on estrogen-sensitive tumor cells.
|
|
|
|
news articles
Depo-Medroxyprogesterone Linked to Raised Diabetes Risk in Some ... Mar 22, 2006
Medscape (subscription) NEW YORK (Reuters Health) Mar 22 - Contraception with depo-medroxyprogesterone acetate (DMPA) is associated with an increase in the risk of diabetes in some ...
No Advantage With Thalidomide For Metastatic Renal Cell Carcinoma Mar 17, 2006
UroToday, NEW YORK (Reuters Health) - Thalidomide is no more effective than medroxyprogesterone acetate for patients with metastatic renal cell carcinoma (RCC), and is ...
Depo Provera may up diabetes risk in some women Mar 22, 2006
Reuters NEW YORK (Reuters Health) - Contraception with depot medroxyprogesterone acetate is associated with an increase in the risk of diabetes in some Latino women ...
Estrogen and Heart Health Mar 28, 2006
Journal of American Medical Association (subscription), Previous reports had indicated that conjugated equine estrogens with continuous medroxyprogesterone acetate provided no protection against coronary heart ...
No Advantage With Thalidomide for Metastatic Renal Cell Carcinoma Mar 14, 2006
Cancerpage.com, NEW YORK MAR 13, 2006 (Reuters Health) - Thalidomide is no more effective than medroxyprogesterone acetate for patients with metastatic renal cell carcinoma ...
Single hormone injection helps with hot flashes Mar 9, 2006
Zee News, New York, Mar 09: A single injection of the hormone Medroxyprogesterone Acetate (MPA) is more effective in reducing menopausal hot flashes than is treatment ...
Single hormone injection helps with hot flashes Mar 7, 2006
Reuters.uk, NEW YORK (Reuters Health) - A single injection of the hormone medroxyprogesterone acetate (MPA) is more effective in reducing menopausal hot flashes than is ...
Hysterectomy costly way to treat uterine bleeding Mar 9, 2006
Reuters ...colleagues calculated the medical resource use of 58 women randomly assigned to hysterectomy or to drug treatment with cyclic medroxyprogesterone acetate for ...
Is there any role for thalidomide as a monotherapy in the ... Mar 8, 2006
News-Medical.net, ...setting. In this report by Lee and colleagues, thalidomide as a monotherapy is compared to medroxyprogesterone acetate (Megace). ...
BioSante Pharmaceuticals Presents Bio-E-Gel(TM) Data at The ... Mar 10, 2006
Genetic Engineering News, ...women (50 to 79 years of age) during 5 years of treatment with oral conjugated equine estrogens (CEE 0.625 mg) combined with medroxyprogesterone acetate (MPA ...
Women's Health: Hysterectomy and Other Treatments for Uterine ... Mar 10, 2006
Community Dispatch (press release) ...attitudes about uterine conservation, and intensity of symptoms affect premenopausal women's satisfaction with use of oral medroxyprogesterone acetate to ...
Class action suit filed over birth control drug Dec 19, 2005
CTV.ca, ...defend a class action lawsuit filed against the company in Ontario Superior Court in relation to Depo-Provera (medroxyprogesterone acetate suspension for ...
WHI Trial Seen Flawed; Alternative Hormone Replacement Regimen ... Dec 16, 2005
Medscape (subscription) Another flaw was that the WHI investigators tested continuous combined conjugated equine estrogen plus medroxyprogesterone acetate (Prempro) in women with a ...
Consumer Reports Medical Guide & Consumer Reports: Prescription ... Dec 5, 2005
U.S. Newswire (press release), ...and others) to treat symptoms of menopause; Isotretinoin (Accutane) for severe acne; Malathion (Ovide) for head lice; Medroxyprogesterone injections (Depo ...
Dr. Bill Elliott: Hormone therapy may be best way to ease hot ... Nov 21, 2005
Marin Independent-Journal, All the women in WHI were on a product known as Prempro, a combination of conjugated estrogen and medroxyprogesterone. Many physicians ...
|
|
